ABSTRACT. I have developed a congenic mouse strain for the A y allele at the agouti locus in an inbred DDD/Sgn strain, DDD.Cg-A y . DDD.Cg-A y females are extremely obese and significantly heavier than B6.Cg-A y females. The objectives of this study were to determine the genetic basis of obesity in DDD.Cg-A y mice, and to determine whether or not their high body weight was due to the presence of DDD background-specific modifiers. I performed quantitative trait locus (QTL) analyses for body weight and body mass index in two types of F 2 mice [F 2 A y (F 2 mice carrying the A y allele) and F 2 non-A y (F 2 mice without the A y allele)] produced by crossing C57BL/6J females and DDD.Cg-A y males. The results of the QTL analysis of F 2 A y mice were very similar to those obtained for F 2 non-A y mice. It was unlikely that the high body weight of DDD.Cg-A y mice was due to the presence of specific modifiers. When both F 2 datasets were merged and analyzed, four significant body weight QTLs were identified on chromosomes 6, 9, and 17 (2 loci) and four significant obesity QTLs were identified on chromosomes 1, 6, 9, and 17. Although the presence of DDD background-specific modifiers was not confirmed, a multifactorial basis of obesity in DDD.Cg-A y females was thus revealed. In normal mice, the agouti gene is expressed only in the skin [2, 15] and regulates pigmentation by serving as an inverse agonist of the melanocortin 1 receptor (MC1R) [9, 20] . However, in A y mice, the agouti gene is ectopically overexpressed [4, 15] because the A y allele is associated with a large deletion and agouti gene expression is controlled by an unrelated Raly gene promoter [13, 14] . Obesity in A y mice is thought to be a consequence of the fact that the agouti protein serves as a constitutive antagonist of the melanocortin 3 receptor (MC3R) and melanocortin 4 receptor (MC4R) by mimicking the action of the agouti-related protein [3, 6, 19] . In particular, MC4R exerts its physiologic effects on feeding by mediating signals from melanocortin peptides downstream of leptin signaling. At present, details of the molecular signaling mechanisms leading to obesity are not yet fully understood.
The magnitude of phenotypic effects of the A y allele appears to depend on the genetic background, i.e., the location of the A ) mice, and we previously identified a quantitative trait locus (QTL), body weight QTL 2 (Bwq2) [23, 24] . Bwq2 is located on the middle of chromosome 6; many gene loci that are relevant to body weight and obesity have been mapped to this chromosome as plausible candidate genes. Identifying causative nucleotide changes is a challenging task; nevertheless, it appears to be a promising approach for searching modifier gene loci and testing their candidacy as QTL genes, because such modifier genes will interact with a known gene whose in vivo relevance has been proven.
I 
MATERIALS AND METHODS

Mice:
The inbred mouse DDD/Sgn ("original" DDD) strain was maintained at the National Institute of Agrobiological Sciences (NIAS, Tsukuba, Ibaraki). The inbred mouse B6 strain was purchased from Clea Japan (Clea Japan Inc., Tokyo). The congenic mouse B6-A y strain was purchased from the Jackson laboratory (Bar Harbor, ME 
, DXMit119, and DXMit64. All F 2 mice (n = 298) were genotyped for the underlined microsatellite markers. Due to the design of the cross, chromosomal regions surrounding the agouti locus (a) on chromosome 2 and the tyrosinase locus (Tyr) on chromosome 7 could not be fully analyzed.
Normality of the trait data distribution in each F 2 type was tested using the Shapiro-Wilk W test (JMP 8, SAS Institute Japan, Tokyo). If the trait values did not follow a normal distribution, they were appropriately normalized by BoxCox transformation.
Initially, F 2 A y and F 2 non-A y mice were analyzed independently for single QTL using the "Marker regression" and "Interval mapping" functions of Map Manager QTX b20 software [11] . The threshold likelihood ratio statistics (LRS) for suggestive (P<0.63), significant (P<0.05), and highly significant (P<0.001) linkages at the genome-wide 5% level was determined by performing 1,000 permutations for each trait. The LRS was converted to a likelihood of odds (LOD) score by dividing by 4.605. For chromosomal regions showing LOD scores exceeding the threshold for significant linkage, all microsatellite makers were genotyped for the remaining mice in both F 2 types. For chromosomal regions showing LOD scores exceeding the threshold for suggestive linkage, microsatellite markers locating such regions were genotyped for the remaining mice in each F 2 type. After simple interval mapping, the potential interaction between marker loci was evaluated pairwise. For this purpose, the following 2-stage test was used: (1) The threshold for significance at the genome-wide 5% level was determined by performing 1,000 permutations on the interaction model of Map Manager QTX; then the significance of the total effect of the two loci was tested (2) When pairs of loci showed a LOD score exceeding the threshold (approximate LOD score 8.6), the significance of the pairwise interaction was evaluated. According to the instruction manual of Map Manager QTX, the interaction effect itself must have a P value less than 0.01. In this study, I also employed a stringent criterion that only those pairs of loci showing interaction LOD scores of 3 would be recognized as indicating a significant interaction [10, 18] . cDNA sequencing of histamine receptor H1 (Hrh1): Because Hrh1 is a plausible candidate gene for body weight QTL on chromosome 6 [28] , the Hrh1 cDNA sequence was determined in the DDD strain. For Hrh1 sequencing, mRNA was extracted from the brain using the QuickPrep micro mRNA purification kit (GE Healthcare UK Ltd., UK). Reverse transcription was performed using the TaKaRa RNA PCR kit (AMV) Ver. 3.0 (Takara Bio Japan Inc., Shiga, Japan). The ORF was amplified and directly sequenced using the following sets of PCR primers: 5'-GAGTGAAACCCGATGCTTGT-3' and 5'-AGAGGT-CACCTTGGGGTCTT-3', and 5'-AAGCTGAGGTCG-GAG-GATG-3' and 5'-GAATGCCTTCACACTGCTCA-3'.
Other statistics:
Statistical analysis between 2 groups was performed using Student's or Welch's t-test. P<0.05 was considered to be statistically significant. ), and DDD females were significantly heavier than B6 females (P<9.6×10 -9 ). Table 1 shows the results of single QTL scans. No significant QTLs were identified in F 2 non-A y mice, whereas four significant QTLs were identified in F 2 A y mice. Two significant QTLs for body weight were identified on chromosomes 6 and 17 (proximal locus) (Figs. 3A and 3B ). I named these loci Body weight in DDD QTL no.2 (Bwdq2, because Bwdq1 was previously assigned [22] ) and Bwdq3, respectively. Two significant QTLs for BMI were identified on chromosomes 6 and 9 (Figs. 3A and 3C ). I named these loci Obesity in DDD QTL no. 1 (Obdq1) and Obdq2, respectively.
RESULTS
Comparison of body weight among DDD, DDD-
Body weight and BMI in B6 × DDD-
Next, data on F 2 non-A y and F 2 A y mice were merged and reanalyzed and eight significant QTLs were identified (Table 2) . With regard to these QTLs, no statistically significant interactions were identified between the genotype of the microsatellite marker nearest to the QTL and the agouti genotype (see below), i.e., allele effects of QTLs were in the same direction in F 2 non-A y and F 2 A y mice. For body weight, four significant QTLs were identified on chromosomes 6, 9, and 17 (proximal and distal loci) (Figs. 3A-C) . I named the locus on chromosome 9 as Bwdq4, and the locus on chromosome 17 (distal locus) as Bwdq5. For BMI, four significant QTLs were identified on chromosomes 1, 6, 9, and 17 (distal locus) (Figs. 3A-D) . I named the locus on chromosome 1 as Obdq3, and the locus on chromosome 17 (distal) as Obdq4. LOD score plot curves were similar between F 2 non-A Genome-wide scans for interacting QTLs: Potential interactions were analyzed pairwise only in the separate F 2 datasets (not in the merged F 2 dataset). The permutation- derived threshold LOD score for the significance of the total LOD score for association was 8.6. In F 2 non-A y mice, no significant interactions were identified. In F 2 A y mice, one significant interaction was identified between D9Mit59 and D17Mit164 for body weight (Fig. 4) . The total LOD score for association was 9.7 and the interaction LOD score was 3.7. Both loci were the nearest markers for significant body weight QTLs, and therefore, I did not assign novel symbols CI is defined by a 1.5-LOD support interval and is determined only for significant QTLs. d) Maximum LOD score for QTL. Significant, and highly significant QTLs are indicated by * and **, respectively (suggestive QTLs are shown without an asterisk). e) Allele that is associated with higher trait values. f) Assignment of a QTL name was limited to significant and highly significant QTLs. g) A proximal end of CI cannot be determined because it extends proximally. 
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to them. Hrh1 cDNA sequencing: Because Hrh1 is a plausible candidate gene for Bwdq2 on chromosome 6, the Hrh1 cDNA sequence was determined in the DDD strain and compared with that in the B6 strain. A nucleotide substitution was identified at nucleotide 1,430 (nucleotide numbering was based on GenBank entry NM_008285); B6 strain had T (CTT), while DDD strain had C (CTC). This nucleotide substitution was not accompanied by an amino acid change.
DISCUSSION
A multifactorial basis of obesity in DDD-A y strain females was revealed. It is unlikely that the high body weight of DDD-A y mice was due to the presence of specific modifiers, although some genomic regions, including mitochondria and parts of chromosomes 2, 7, and X, were only poorly analyzed.
I speculate the reason why only females are obese in DDD-A y strain may be related to a difference in hormonal conditions between males and females. DDD strain is known to have higher blood testosterone levels than does B6 strain [5] . According to Moulana et al. [17] , obesity is associated with reductions in testosterone levels in men, whereas obesity is associated with increases in testosterone levels in women. Therefore, it appears to be possible to consider that a part of reason for the female-specific obesity in DDD-A y strain is related to a difference in hormonal conditions between males and females.
For body weight, two significant QTLs were identified on chromosomes 6 and 17 (proximal) in F 2 A y mice, whereas no significant QTLs were identified in F 2 non-A y mice. For BMI, two significant QTLs were identified on chromosomes 6 and 9 in F 2 A y mice, whereas no significant QTLs were identified in F 2 non-A y mice. Furthermore, one significant interaction was identified between D9Mit59 and D17Mit164 for body weight but only in F 2 A y mice. Therefore, these QTLs were suggested as modifier loci for the A y allele. However, all significant QTLs identified in F 2 A y mice, except for the locus on chromosome 17, were also 6.7 ** D17Mit123 DDD Obdq4 a) Chromosome. b) Location means a chromosomal position showing a peak LOD score in cM units. c) 95% CI is defined by a 1.5-LOD support interval, and is determined only for significant QTLs. d) Maximum LOD score for QTL. Significant, and highly significant QTLs are indicated by * and **, respectively (suggestive QTL are shown without an asterisk). e) Allele that is associated with higher trait values. f) Assignment of a QTL name was limited to significant and highly significant QTLs. g) A proximal end of CI cannot be determined because it extends proximally. h) A distal end of CI cannot be determined because it extends distally. suggestive QTLs in F 2 non-A y mice. Thus, it appeared inadequate to regard these QTLs as modifier loci. Furthermore, except for QTL on chromosome 9, the B6 allele was associated with increased body weight and/or BMI at all loci. It was not surprising that the lean strain-derived allele was associated with increased body weight [26, 27] , but it was troublesome that the B6 allele was associated with increased body weight at majority of the loci. Nevertheless, there are explanations to account for this discrepancy. First, the DDD allele was associated with increased trait values at all suggestive loci except for the locus on chromosome 14 for body weight. Thus, the cumulative contribution of these suggestive loci should not be underestimated. Indeed, the suggestive QTLs on distal chromosome 17 (Table 1) were identified as significant QTLs for both body weight and BMI with the second highest LOD scores in merged F 2 dataset (Table 2) . Second, the contribution of the mitochondrial genome of the DDD strain was lost in F 2 analysis because the F 2 generation was derived from B6 females and DDD-A y males. Likewise, X-linked genes were not fully analyzed in this study. The F 2 mice were either homozygous for the B6 allele or heterozygous for the X-linked loci; mice homozygous for the DDD allele were absent. Thus, if a putative X-linked QTL from the DDD strain is associated with increased body weight and a recessive inheritance mode, it could not be detected. Third, it should be noted that and wild-type Tyr alleles, and their neighboring genome were introgressed from the B6 strain (with regard to chromosome 7, the introgressed region was limited to a maximum of 45-64.2 cM based on the estimation of microsatellite polymorphisms). Thus, the high body weight of the DDD-A y strain may be intrinsically sustained by the B6 genome on chromosomes 2 and 7 in combination with the rest of the DDD genome. I cannot deny the possibility that the B6-derived genes in these chromosomal regions contain the principal QTL for enhanced obesity in DDD-A y mice. It should be noted that unlike the "original" DDD strain, DDD mice also had a B6-derived genome on chromosome 7.
It was noted that the results of QTL analysis from two separate F 2 types showed high similarity; for example, loci for body weight on chromosomes 6 and 17 (distal) and those for BMI on chromosome 6, 9, and 17 (distal) were common for the two F 2 types (Table 1) . Therefore, data of both F 2 types were merged and reanalyzed. As expected, statistical power to detect significant QTLs increased, i.e., LOD scores for some suggestive QTLs identified in the separate F 2 dataset exceeded the significance threshold in the merged F 2 dataset. In addition, no significant interactions were identified between the genotypes of the microsatellite marker nearest to the QTL and the agouti genotype in the merged F 2 dataset. This in turn justifies the QTL analyses performed in the merged F 2 dataset. As a result, four significant QTLs were identified for body weight and BMI, respectively. Taken together, the high body weight of DDD-A y mice was probably because DDD strain is heavier than B6, and not because of specific modifiers. Differences of body weight between DDD-A y and B6-A y as well as between DDD and B6 strains were explained by the same set of loci. It is thus possible to regard the DDD-A y female as a mouse strain of multifactorial obesity.
Many QTLs that are coincidental with the present ones have been reported. For example, Bwq2 [24] and Tabw2 [8] apparently overlap with Bwdq2 and Obdq1 on chromosome 6. We previously identified Bwq2 as a modifier QTL for the A y allele in an F 2 intercross between B6 and obese KK-A y strains [23, 24] . Similar to Bwq2, the effects of Bwdq2 and Obdq1 were stronger in F 2 A y than in F 2 non-A y mice. However, in contrast to Bwq2, the lean strain (B6)-derived allele at Bwdq2 and Obdq1 was associated with increased body weight and obesity. Tabw2 was identified in the TallyHo strain, which is a multigenic mouse model of non-insulindependent diabetes mellitus with obesity [8] . At Tabw2, the TallyHo-derived allele was associated with increased body weight. Allelism among these loci is unclear. Hrh1 is a plausible candidate gene for body weight QTL identified in the middle of chromosome 6 because Hrh1 constitutes part of the leptin signaling pathway in a way similar to MC4R, and because central administration of histamine decreases body weight and adiposity in A y mice [12] . I could not find any mutations in the coding sequence of Hrh1 in DDD and KK mice [23] . Kim et al. [8] also analyzed Hrh1 as a candidate gene, and found no nucleotide changes between TallyHo and B6 alleles. Needless to say, this chromosome 6 region contains many other candidate genes relevant to body weight and obesity; for example, peroxisome proliferator activated receptor gamma, thyrotropin releasing hormone, and ghrelin [28] . Their candidacy remains to be investig a t e d .
Proximal chromosome 17 is also known to contain several obesity QTLs. For example, Obq4a [25] , Obq4b [27] , and Obq19 [7] apparently overlap with Bwdq3. Bwdq3 was a significant QTL for body weight, but not for obesity (BMI). In contrast, Obq4a, Obq4b, and Obq19 were identified for obesity using an adiposity index or BMI. Results for body weight, BMI, and adiposity should not be simply compared with one another, and indeed, the effects of Obq4a on body weight and BMI were modest (i.e., LOD scores were 1.5 for body weight and 1.6 for BMI). The effects of Obq4b and Obq19 on body weight were not described. Thus, it is unclear whether Bwdq3 was allelic with one or more of the remaining QTLs. Nevertheless, it is interesting and important to note that at Obq4a, Obq4b, Obq19, and Bwdq3 loci, the allele from the lean strain was associated with increased adiposity and/or body weight. In contrast to the proximal locus, only a few coincidental QTLs have been reported for the locus on distal chromosome 17. Allan et al. [1] analyzed growth and body composition in a large F 2 population resulting from an intercross between M16 and ICR and identified several QTLs for body weight, growth, and fat-ness. The M16 line is more obese than ICR, and the M16 allele is associated with increases in these trait values, in a way similar to Bwdq5 and Obdq4.
Other significant QTLs for body weight (Bwdq4) and BMI (Obdq2) were mapped to the centromeric end of chromosome 9 (Fig. 3C) . Obq5, identified in an F 2 intercross between KK/HlLt and B6, was mapped to the proximal portion of chromosome 9 [26] . Based on the LOD score, effect of Obq5 was stronger for adiposity than for body weight in females. However, the location of the 1.0-LOD support interval appeared to be slightly distal to Bwdq4 and Obdq2 in females. Su et al. [21] identified the body fat QTL Obq32 on proximal chromosome 9 in an F 2 intercross between B6 and 129S1/SvlmJ, but its effect was significant only in males. Thus, sex specificity was noted for QTL on chromosome 9. Bwdq4 as well as Obdq2 may be novel QTLs in mice.
Several studies have reported the presence of obesity QTL on chromosome 1. Moody et al. [16] identified Fatq1 for fat weight in an F 2 intercross between MH and B6. Taylor et al. [27] identified Obq8 for adiposity in an F 2 intercross between NZO and SM. Ishimori et al. [7] identified Obq17 for fatness in a F 2 intercross between B6 and 129S1/ SvlmJ. Vogel et al. [29] identified Nob3 for obesity in an F 2 intercross between NZO and B6. Obq8 and Nob3 were identified in crosses containing the obese NZO strain, thus suggesting that they were allelic. Nob3 was also significant for body weight. In this study, Obdq3 was not significant for body weight, but significant for obesity. Thus, Obdq3 may not be allelic with Obq8 and Nob3.
Pairwise searches for interacting QTLs identified one significant interaction between D9Mit59 and D17Mit164 for body weight in F 2 A y mice. D9Mit59 and D17Mit164 were the nearest markers for Bwdq4 and Bwdq3, respectively. Therefore, the interaction immediately suggests functional relationships between these QTLs. These loci were fully genotyped in all F 2 mice. However, many other loci were genotyped in a limited number of mice. Hence, I cannot deny the possibility that I missed additional interacting QTLs.
In conclusion, although the presence of DDD background-specific modifiers was not confirmed, a multifactorial basis of obesity in DDD-A y strain females was revealed.
